Text size A A

News

Date Title and Summary Additional Formats
Toggle Summary AGTC Raises $15,250,000 in Series A-1 Round
AGTC Raises $15,250,000 in Series A-1 Round December 1, 2003 - Applied Genetic Technologies Corporation, AGTC, a drug research company developing novel human therapeutics, announces that the Company has closed on a $15,250,000 Series A-1 Round led by InterWest Partners of Menlo Park, CA.
View HTML
Visionary science for life changing cures.